Annual Meeting: March 15 – 19, 2020
ToxExpo: March 16 – 18, 2020
Anaheim Convention Center, Anaheim, California
Genesis Drug Discovery and Development (GD3) is a preclinical CRO offering a comprehensive portfolio of services to ensure the efficient development and coordination of unique preclinical programs, from discovery through candidate selection. Services include advanced in vivo testing capabilities in biochemical & molecular biology, creation and testing of patient-derived cancer xenograft models, synthetic organic, & medicinal chemistry, and small molecule drug target validation.
@ToxExpo on Twitter
11190 Sunrise Valley Dr, Ste 300, Reston, VA 20191
Exhibitor Service Center
Anaheim Convention Center
800 W Katella Ave
Anaheim, CA 92802
Copyright 2018, a2z, Inc. All rights reserved.